Published in Am J Obstet Gynecol on September 15, 1976
Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol (2013) 1.21
Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause (2009) 1.04
Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor? Int J Hyperthermia (2010) 0.97
Physiological aspects of menopausal hot flush. Br Med J (1978) 0.89
A novel animal model to study hot flashes: no effect of gonadotropin-releasing hormone. Menopause (2009) 0.75
Menopausal hot flashes are treated effectively by a transdermal, low-dose estradiol spray. Nat Clin Pract Endocrinol Metab (2009) 0.75
Effect of acupuncture on hot flush and menopause symptoms in breast cancer- A systematic review and meta-analysis. PLoS One (2017) 0.75
Treatment of metastatic trophoblastic disease: good and poor prognosis. Am J Obstet Gynecol (1973) 2.12
Restructuring residency training in obstetrics and gynecology. Am J Obstet Gynecol (1999) 2.01
Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res (1996) 1.91
Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol Sci (2000) 1.46
The effect of aging on hypothalamic function in oophorectomized women. Am J Obstet Gynecol (1990) 1.40
Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol (1979) 1.39
Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol (1979) 1.39
Hydatidiform mole: diagnosis, management, and long-term followup of 347 patients. Obstet Gynecol (1975) 1.23
Gestational trophoblastic disease metastatic to the central nervous system. Gynecol Oncol (1995) 1.15
Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. J Clin Endocrinol Metab (1984) 1.14
The pulmonary metastases of choriocarcinoma. Obstet Gynecol (1977) 1.14
False positive hCG. Obstet Gynecol (2001) 1.13
Effect of atrazine on ovarian function in the rat. Reprod Toxicol (1997) 1.09
Estrous cycle patterns of Sprague-Dawley rats during acute and chronic atrazine administration. Reprod Toxicol (2000) 1.07
Pseudoobstruction of the colon complicating choriocarcinoma. Gynecol Oncol (1985) 1.07
Epidermoid cyst of the paravaginal space located only by computerized axial tomography. A case report. J Reprod Med (1982) 1.06
Diagnostic problems of choriocarcinoma and related trophoblastic neoplasms. Obstet Gynecol (1967) 1.06
5-day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol (1994) 1.03
Continuous estrogen/progestin therapy in menopause. Am J Obstet Gynecol (1987) 1.02
Disruption of the mouse oestrogen receptor gene: resulting phenotypes and experimental findings. Biochem Soc Trans (1995) 0.99
The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol (1980) 0.99
Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse. Endocrinology (1999) 0.99
Diethylstilbestrol-induced upper genital tract abnormalities. Fertil Steril (1979) 0.98
Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life. Obstet Gynecol (1984) 0.97
Risk of exogenous estrogen therapy and endometrial cancer. Am J Obstet Gynecol (1980) 0.97
Cerebral metastatic choriocarcinoma: intensive therapy and prognosis. Obstet Gynecol (1980) 0.94
Current status of estrogen therapy for the menopause. Fertil Steril (1982) 0.93
Developmental coordination of luteinizing hormone/human chorionic gonadotropin (hCG) receptors and acute hCG responsiveness in cultured and freshly harvested porcine granulosa cells. Endocrinology (1984) 0.93
Signet-ring cell carcinoma of the endometrium: a primary tumor masquerading as a metastasis. Int J Gynecol Pathol (1997) 0.93
Growth factors modulate gonadotropin receptor induction in granulosa cell cultures. Science (1981) 0.92
Conservative treatment of endometriosis: 1978. Fertil Steril (1978) 0.92
Evidence for a hypothalamic defect in septo-optic dysplasia. Arch Intern Med (1978) 0.90
Life-threatening hemorrhage complicating sacral colpopexy. Am J Obstet Gynecol (1981) 0.90
High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. Int J Gynecol Cancer (2006) 0.90
Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease. Obstet Gynecol (1994) 0.89
2-Methoxyestradiol, an endogenous estradiol metabolite, differentially inhibits granulosa and endothelial cell mitosis: a potential follicular antiangiogenic regulator. Biol Reprod (2001) 0.89
Renal metastases of gestational trophoblastic disease: a report of eight cases. Obstet Gynecol (1988) 0.88
Restricted expression of WT1 messenger ribonucleic acid in immature ovarian follicles: uniformity in mammalian and avian species and maintenance during reproductive senescence. Biol Reprod (1999) 0.88
Pain relief in hysterosalpingography. A comparison of analgesics. J Reprod Med (1990) 0.87
Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients. Obstet Gynecol (1988) 0.86
Human chorionic gonadotropin: structural, biologic, and immunologic aspects. Semin Oncol (1982) 0.86
Diagnostic and therapeutic uses of gonadotropin-releasing hormone. Arch Intern Med (1985) 0.86
Plasma and urinary chorionic gonadotropin during early human pregnancy. Obstet Gynecol (1968) 0.85
Endocrine problems in the menopause. Clin Obstet Gynecol (1982) 0.85
Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center. Cancer (1990) 0.84
Hormonal characteristics of long cycles in fertile women. Fertil Steril (1981) 0.84
Biochemical evidence that human placental lactogen and human chorionic gonadotropin are not stored in cytoplasmic secretion granules. Biol Reprod (1987) 0.84
Angiographic demonstration of arteriovenous shunts in pulmonary metastatic choriocarcinoma. Radiology (1973) 0.83
Treatment of metastatic trophoblastic disease with poor prognosis. Obstet Gynecol (1980) 0.83
Acute childbirth morbidity: its measurement using hospital charges. Am J Obstet Gynecol (1992) 0.83
Influence of anterior hypothalamic lesions on circulating antibody titers in the rat. Am J Physiol (1972) 0.83
Choriocarcinoma following term pregnancy. Obstet Gynecol (1979) 0.83
Statistical evaluation of coincident prolactin and luteinizing hormone pulses during the normal menstrual cycle. J Clin Endocrinol Metab (1988) 0.83
Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate--folinic acid. Am J Obstet Gynecol (1982) 0.83
Human granulosa-luteal and cumulus cells express transforming growth factors-beta type 1 and type 2 mRNA. J Clin Endocrinol Metab (1992) 0.83
Role of surgical therapy and radiotherapy in gestational trophoblastic disease. J Reprod Med (1987) 0.82
The occurrence of adenocarcinoma in endometriosis of the rectovaginal septum during progestational therapy. Gynecol Oncol (1979) 0.82
Conservative treatment of endometriosis: the effects of limited surgery and hormonal pseudopregnancy. Fertil Steril (1976) 0.82
Differential synthesis of human placental lactogen and human chorionic gonadotropin in vitro. Endocrinology (1978) 0.82
The production of transforming growth factor-beta activity by rat granulosa cell cultures. Endocrinology (1989) 0.82
Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease. Obstet Gynecol (1986) 0.82
Follicle-stimulating hormone-mediated induction of functional luteinizing hormone/human chorionic gonadotropin receptors during monolayer culture of porcine granulosa cells. Endocrinology (1980) 0.82
The effect of a biodegradable contraceptive capsule (Capronor) containing levonorgestrel on gonadotropin, estrogen, and progesterone levels. Am J Obstet Gynecol (1983) 0.82
Changing rates of cesarean delivery: the Duke experience, 1978-1986. Obstet Gynecol (1988) 0.82
Luteinizing hormone requirements for ovulation in the pentobarbital-treated proestrous rat. Endocrinology (1976) 0.82
Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium. Obstet Gynecol (1994) 0.81
Choriocarcinoma metastatic to the brain: therapy and prognosis. Semin Oncol (1982) 0.81
Pregnancy following the "insensitive ovary syndrome". Fertil Steril (1977) 0.81
Endocrine aspects of trophoblastic neoplasia. J Reprod Med (1981) 0.81
Differential effects of epidermal growth factor, somatomedin-C/insulin-like growth factor I, and transforming growth factor-beta on porcine granulosa cell deoxyribonucleic acid synthesis and cell proliferation. Endocrinology (1988) 0.81
Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms. Am J Obstet Gynecol (1967) 0.81
Apoptosis in atretic ovarian follicles is associated with selective decreases in messenger ribonucleic acid transcripts for gonadotropin receptors and cytochrome P450 aromatase. Endocrinology (1992) 0.80
Changes in (125I) labeled human chorionic gonadotropin (hCG) binding to porcine granulosa cells during follicle development and cell culture. Endocrinology (1976) 0.80
Normal pregnancy and delivery after cerebral metastases of choriocarcinoma: Case report. Cancer (1976) 0.80
Uterine artery ligation for postabortal hemorrhage. Obstet Gynecol (1979) 0.80
Cushing's disease caused by an ectopic pituitary adenoma within the sphenoid sinus. N Engl J Med (1985) 0.79
Failure of L-tryptophan to stimulate prolactin secretion in man. J Clin Endocrinol Metab (1977) 0.79
Pulmonary resection in the management of metastases from gestational choriocarcinoma. J Thorac Cardiovasc Surg (1981) 0.79
The estrogen-induced advance in the cyclic LH surge in the rat: dependency on ovarian progesterone secretion. Endocrinology (1973) 0.79
Steroidal modulation of progesterone secretion by granulosa cells from large porcine follicles: a role for androgens and estrogens in controlling steroidogenesis. Biol Reprod (1978) 0.79
Premenstrual syndrome and related hormonal changes. Long-acting gonadotropin releasing hormone agonist treatment. J Reprod Med (1993) 0.78
Are estrogens indicated for the treatment of postmenopausal women? Drug Intell Clin Pharm (1988) 0.78
Anterior sacral meningocele presenting as a pelvic mass and diagnosed only at celiotomy after an extensive workup. A case report. J Reprod Med (1983) 0.78
The effect of transforming growth factor-beta on follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology (1987) 0.78
delta-9-Tetrahydrocannabinol suppression of episodic luteinizing hormone secretion in the ovariectomized rat. Endocrinology (1978) 0.78
Diagnosis of prolactin-secreting pituitary microadenoma. Am J Obstet Gynecol (1976) 0.78
Immunologic aspects of reproductive diseases. JAMA (1992) 0.78
Transforming growth factor beta modulates gonadotropin receptor expression in porcine and rat granulosa cells differently. Biol Reprod (1993) 0.78
Prolactin secretion preceding delayed pseudopregnancy in rats after electrical stimulation of the hypothalamus. Endocrinology (1978) 0.78
Synergistic effect of insulin and follicle-stimulating hormone on biochemical and morphological differentiation of porcine granulosa cells in vitro. Biol Reprod (1988) 0.78
Estrogen-replacement therapy--help or hazard? N Engl J Med (1979) 0.78
In vitro lymphocyte activity in women with endometriosis--an altered immune response? Fertil Steril (1992) 0.78
A pelvimetry method for predicting perinatal mortality in pregnant squirrel monkeys (Saimiri sciuresus). Lab Anim Sci (1983) 0.78
Plasma prostaglandin F 2-alpha levels in dysmenorrehic women. Fertil Steril (1976) 0.78